Company: APM
Filing Date: 2025-04-30
Form Type: 20-F
Source: 0001213900-25-037669
Chunk: 159

Company: Aptorum Group Ltd
Filing Date: 2025-04-30
Form: 20-F
Item: Item 4A
Chunk 159
---
 net, was $217,196 and other income, net, was $6,383,276, respectively. The changes from other income
in 2023 to other expense in 2024 was mainly due to there was a one-off unrealized gain from fair value change of the long-term investments,
amounted to $6.4 million in prior year, which there are no such gain in current year.

Net loss attributable to Aptorum Group Limited

For the years ended December 31,
2024, and 2023, net loss attributable to Aptorum Group Limited (excluding net loss attributable to non-controlling interests) was $4,267,806
and $2,824,647, respectively.

Results of Operations for the Years ended
December 31, 2023, and 2022

During the second quarter
of 2023, the Company made a decision to streamline its operations by terminating clinic services and suspending non-lead R& D projects.
This measure is aimed at optimizing the allocation of our resources and focusing our efforts on advancing our lead projects, which hold
the most promise for commercial success and beneficial impact. This decision aligns with our commitment to enhance shareholder value and
effectively drive our core objectives forward in the competitive landscape.

The following table summarizes
our results of operations for the years ended December 31, 2023, and 2022.

  Revenue                                                                                                     
  Healthcare services income                                                        431,378        1,295,889  
  Operating expenses                                                                                          
  Cost of healthcare services                                                      (420,812       (1,215,824  
  Research and development expenses                                              (5,198,329       (9,219,595  
  General and administrative fees                                                (1,930,637       (5,220,405  
  Legal and professional fees                                                    (2,538,161       (2,888,140  
  Other operating expenses                                                       (1,067,690         (261,038  
  Total expenses                                                                (11,155,629      (18,805,002  
  Other income, net                                                                                           
  Loss on investments in marketable securities, net                                  (9,266         (134,134  
  Unrealized gain from fair value change of the long-term investments, net        6,431,088        6,108,872  
  Impairment loss of long-term investment                                           (77,200         (520,821  
  Interest (expense) income, net